Evidence map›Paper›PMID 42888325›Full record

ArticleCardiovascular engineering and technology2026

Comparative Evaluation of Power-Law and Viscoelastic Hemolysis Models in the FDA Nozzle Benchmark Geometry.

Alberto Girelli, Giulia Giantesio, Adélia Sequeira, Tomáš Bodnár

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular engineering and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alberto GirelliDipartimento di Matematica e Fisica "N. Tartaglia", Università Cattolica del Sacro Cuore, Brescia, Italy.ORCID http://orcid.org/0000-0003-3581-7726
Giulia GiantesioDipartimento di Matematica e Fisica "N. Tartaglia", Università Cattolica del Sacro Cuore, Brescia, Italy. giulia.giantesio@unicatt.it.ORCID http://orcid.org/0000-0002-7303-7408
Adélia SequeiraDepartment of Mathematics and CEMAT, Instituto Superior Técnico, University of Lisbon, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-4216-6960
Tomáš BodnárDepartment of Technical Mathematics, Faculty of Mechanical Engineering, Czech Technical University, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-2991-8467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe mechanical damage of red blood cells (hemolysis) remains a key challenge in the design of blood-contacting medical devices. This study aims to compare the predictive performance of the empirical power-law model and the physiologically motivated viscoelastic model in the FDA nozzle benchmark geometry, with a focus on how model parameters and shear stress definitions influence hemolysis predictions.

methodsComputational fluid dynamics (CFD) simulations were performed using a finite volume framework to resolve flow fields and shear stresses in the FDA nozzle. Both hemolysis models were implemented under identical geometry, mesh and boundary conditions. A parametric analysis was conducted by varying key model parameters, including the viscoelastic constants A,

conclusionThe viscoelastic model demonstrated strong sensitivity to the relaxation time

backgroundThe viscoelastic model offers a more mechanistic description of hemolysis but requires careful parameter calibration and is highly sensitive to stress definitions. The power-law model remains computationally efficient and easier to implement, though empirical by nature. Future research should refine parameter estimation and extend validation to more complex flow regimes, considering feedback effects of hemolysis on viscosity. Ultimately, CFD prediction of hemolysis remains a challenging unsolved problem.

Indexed as

Blood DamageComparative AnalysisHemolysisNumerical Simulations

Identifiers

PMID42888325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.